Daizo Kato
Nagoya University
24 Papers
169 Citations
Daizo Kato is an academic researcher from Nagoya University. The author has contributed to research in topics: Rheumatoid arthritis & Tocilizumab. The author has an hindex of 12, co-authored 24 publications. Previous affiliations of Daizo Kato include Nagoya City University.
Chat about Author
Papers
Study protocol of a multicenter registry of patients with rheumatoid arthritis starting biologic therapy in Japan : Tsurumai Biologics Communication Registry (TBCR) Study
Toshihisa Kojima,Atsushi Kaneko,Yuji Hirano,Hisato Ishikawa,Hiroyuki Miyake,Takeshi Oguchi,Hideki Takagi,Yuichiro Yabe,Takefumi Kato,Takayasu Ito,Kenya Terabe,Naoki Fukaya,Yasuhide Kanayama,Tomone Shioura,Koji Funahashi,Masatoshi Hayashi,Daizo Kato,H. Matsubara,Takayoshi Fujibayashi,Masayo Kojima,Naoki Ishiguro +20 more
TL;DR: Differences in baseline characteristics by age and initiation year of biologics need to be carefully evaluated in order to report on drug-related survival and long-term prognosis, using follow-up data in the near future.
37
Monitoring C-reactive protein levels to predict favourable clinical outcomes from tocilizumab treatment in patients with rheumatoid arthritis
Toshihisa Kojima,Yuichiro Yabe,Atsushi Kaneko,Yuji Hirano,Hisato Ishikawa,Masatoshi Hayashi,Hiroyuki Miyake,Hideki Takagi,Takefumi Kato,Kenya Terabe,Tsuyoshi Wanatabe,Hiroki Tsuchiya,Daihei Kida,Tomone Shioura,Koji Funahashi,Daizo Kato,H. Matsubara,Nobunori Takahashi,Yosuke Hattori,Nobuyuki Asai,Naoki Ishiguro +20 more
TL;DR: Adequate suppression of pathological IL-6 signalling during TCZ treatment improves clinical outcomes and can be monitored with serum CRP levels, a readily available biomarker in clinical practice.
36
A selective estrogen receptor modulator inhibits tumor necrosis factor-α-induced apoptosis through the ERK1/2 signaling pathway in human chondrocytes.
TL;DR: It is suggested that raloxifene prevents caspase-3-dependent apoptosis induced by TNF-α in human chondrocytes by activating estrogen receptors and the ERK1/2 signaling pathway.
29
Early aggressive intervention with tocilizumab for rheumatoid arthritis increases remission rate defined using a Boolean approach in clinical practice
Toshihisa Kojima,Atsushi Kaneko,Yuji Hirano,Hisato Ishikawa,Hiroyuki Miyake,Hideki Takagi,Yuichiro Yabe,Takefumi Kato,Kenya Terabe,Naoki Fukaya,Hiroki Tsuchiya,Tomone Shioura,Koji Funahashi,Masatoshi Hayashi,Daizo Kato,H. Matsubara,Naoki Ishiguro +16 more
TL;DR: It is shown that remission, as newly defined using a Boolean approach, is a realistic goal for patients treated with tocilizumab with short disease duration in real-world clinical practice.
23
The first point prevalence survey of health care-associated infection and antimicrobial use in a Japanese university hospital: A pilot study.
Hiroshi Morioka,Aki Hirabayashi,Mitsutaka Iguchi,Yuka Tomita,Daizo Kato,Naokazu Sato,Miyuki Hyodo,Naoko Kawamura,Takuya Sadomoto,Kazuya Ichikawa,Takayuki Inagaki,Yoshiaki Kato,Yuichi Kouyama,Yoshinori Ito,Tetsuya Yagi +14 more
TL;DR: The incidence of HAIs is higher in Japan than in other developed countries, and the social and medical situation in Japan may affect patient demographics, active HAIs, and antimicrobial use.
23